Microsoft is rolling out a major overhaul of its Windows Insider Program, aiming to simplify how early Windows features are tested while addressing long-standing user complaints around complexity and ...

Everlaw, the cloud-native investigation and litigation platform, today announced its partnership with Array, a leading litigation support firm. Through the collaboration, Array will incorporate ...

Editor’s note: This story has been updated to correct a typo.Home plate umpire C.B. Bucknor didn’t have his best showing in a game that saw the Cincinnati Reds defeat the Boston Red Sox 6-5 after 11 ...

MIDDLETOWN TOWNSHIP, Pa - Middletown Township police are calling out drivers for ignoring school bus stop signs, saying their new bus patrol program is catching violators and helping improve safety ...

The administration has yet to find a candidate who aligns with Health Secretary Robert F. Kennedy Jr.’s agenda while avoiding his unpopular stance on vaccines. By Apoorva Mandavilli and Sheryl Gay ...

The Bills reacted to their latest failure to get over the hump in the playoffs by firing head coach Sean McDermott and their bid to finally break through has also included moves to bring in players ...

“My family dinner and game nights are sacred – no exceptions, no apologies. My team knows this time is non-negotiable and it makes me sharper and more balanced as a CEO. My kids will remember our ...

The Northern Iowa football program is mourning the death of freshman Parker Sutherland, who passed away Saturday morning according to a release by the school. He was 18 years old. Sutherland, an Iowa ...

Gov. Josh Green has canceled his upcoming plans to travel to Washington, D.C., for the annual National Governors Association’s Winter Meeting to avoid having Lt. Gov. Sylvia Luke fill in for him as ...

The last time I wrote an article on Structure Therapeutics Inc. (GPCR) it was in a Seeking Alpha article entitled "Structure Therapeutics: Potential To Have Best-In-class GLP-1 Agonist For Obesity ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...